Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy: Progress and Pitfalls

Ad W G J Oomen1, Christopher Semsarian2, Rajesh Puranik3

  • 1Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Insights

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart condition causing sudden cardiac death. Diagnosing ARVC is challenging due to a lack of specific indicators, requiring multiple tests for confirmation.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Diagnostics

Background:

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited condition affecting the right ventricle.
  • It is a significant cause of sudden cardiac death in young individuals and athletes.
  • Current diagnostic methods for ARVC present considerable challenges.

Purpose of the Study:

  • To highlight the complexities in diagnosing Arrhythmogenic right ventricular cardiomyopathy (ARVC).
  • To review the current international task force criteria for ARVC diagnosis.
  • To identify limitations and suggest future improvements for ARVC diagnostic protocols.

Main Methods:

  • Review of current international task force criteria for ARVC diagnosis.
  • Analysis of diagnostic modalities including imaging, histology, electrophysiology, and genetic testing.
  • Discussion of the limitations of existing criteria.

Main Results:

  • ARVC diagnosis relies on combining major and minor criteria across six categories.
  • No single diagnostic finding is pathognomonic for ARVC.
  • Current criteria have limitations in specificity, necessitating further refinement.

Conclusions:

  • Diagnosing ARVC is complex and requires integrating data from various sources.
  • Existing diagnostic criteria for ARVC need enhancement for improved accuracy and specificity.
  • Future advancements may involve advanced imaging, electro-anatomical mapping, and genetic variant interpretation.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
588
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
524
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
583
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
466
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
618
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
363